Deena Beasley – Page 7

Bypass tops stents in diabetics with diseased arteries

May 13, 2019 at 9:23 p.m.

LOS ANGELES (Reuters) - Diabetics with more than one diseased artery fared significantly better if they underwent bypass surgery than those who received drug coated stents following artery clearing procedures...

FDA finds fungus in steroid shots, meningitis toll rises

December 24, 2018 at 9:44 p.m.

NEW YORK/LOS ANGELES (Reuters) - U.S. health officials made their first confirmation of the presence of a deadly fungus in one of three lots of steroids tied to a national...

Daily multivitamin shown to help ward off cancer in men

August 23, 2021 at 3:58 p.m.

LOS ANGELES (Reuters) - Swallowing a daily multivitamin can reduce the risk of cancer by at least eight percent in middle-aged and older men and appears to have no dangerous...

Daily multivitamin shown to help ward off cancer in men

May 13, 2019 at 9:04 p.m.

LOS ANGELES (Reuters) - Swallowing a daily multivitamin can reduce the risk of cancer by at least eight percent in middle-aged and older men and appears to have no dangerous...

Analysis: Use of pill to prevent HIV may be limited in U.S

August 23, 2021 at 1:47 p.m.

LOS ANGELES (Reuters) - The first preventive pill for HIV has been hailed as a landmark in the fight against AIDS in the United States, but experts say only a...

Peregrine drug doubles lung cancer survival in trial

August 23, 2021 at 1:45 p.m.

(Reuters) - A small trial of Peregrine Pharmaceuticals Inc's experimental drug, bavituximab, showed that it doubled the length of time lung cancer patients survived, supporting the company's plans to conduct...

Analysis: Use of pill to prevent HIV may be limited in U.S

May 13, 2019 at 8:25 p.m.

LOS ANGELES (Reuters) - The first preventive pill for HIV has been hailed as a landmark in the fight against AIDS in the United States, but experts say only a...

Peregrine drug doubles lung cancer survival in trial

May 13, 2019 at 8:24 p.m.

(Reuters) - A small trial of Peregrine Pharmaceuticals Inc's experimental drug, bavituximab, showed that it doubled the length of time lung cancer patients survived, supporting the company's plans to conduct...

FDA approves Medivation prostate cancer drug

December 24, 2018 at 2:21 p.m.

(Reuters) - A novel prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and Drug Administration for men whose cancer has...

FDA approves Medivation prostate cancer drug

August 23, 2021 at 1:20 p.m.

(Reuters) - A novel prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and Drug Administration for men whose cancer has...

All Stories